© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad

More articles/Ad

More articles

  • A handful of Indian listings that had been expected by the end of March have been pushed back after a traumatic week for domestic and global markets.
  • The outlook for Italy continues to worsen, as both the coronavirus pandemic and financial markets rout deepened on Thursday. But essential services are functioning, in society and markets, and Italians are helping each other through the crisis, including with funding difficulties. By Jon Hay and Lewis McLellan
  • One of the worst ever weeks in markets spared no asset class, and investors warned that Latin America’s mostly commodity-oriented economies were in a particularly bad spot as the region’s oil producers led EM losses in both corporates and sovereigns.
  • As the coronavirus pandemic threatens every facet of capital markets activity, trading floors and back offices have emptied in recent days, leading to questions about how efficiently business can be done from home and alternative sites, write Paola Aurisicchio, Jasper Cox, Jennifer Kang and Ross Lancaster.
  • Financial market tumult and global instability as a result of the coronavirus pandemic are hitting CLO primary issuance, while activity in the secondary market is accelerating as investors hunt for opportunities amid the chaos.
  • JP Morgan faced down a global market rout this week to print its first senior unsecured dollar bond of 2020, jumping ahead of Wall Street rivals before markets froze in fear over the coronavirus pandemic.